PA
PALI icon

Perceptive Advisors’s Palisade Bio PALI Stock Holding History

Perceptive Advisors’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.6M Sell
8,425,065
-503,084
-6% -$990K 0.26% 63
2026
Q1 		$15.6M Sell
8,928,149
-3,121,851
-26% -$5.68M 0.31% 60
2025
Q4 		$28.3M Buy
+12,050,000
New +$23.2M 0.5% 49

Other funds holding PALI

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $213M AUM 96.05% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Perceptive Advisors's PALI Position: Q2 2026 in Review

Perceptive Advisors reduced its Palisade Bio (PALI) stake by 5.6% in Q2 2026, selling an estimated $990K and leaving 8,425,065 shares worth $17.6M. The position accounts for 0.26% of the portfolio, ranked #63.

Perceptive Advisors first reported a position in PALI in Q4 2025 and has held it in 3 quarters since. The position peaked at $28.3M in Q4 2025. 124 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

  • Perceptive Advisors held 8,425,065 shares of Palisade Bio worth $17.6M as of Q2 2026.
  • Perceptive Advisors sold 503,084 Palisade Bio shares in Q2 2026, an estimated $990K.
  • Palisade Bio made up 0.26% of Perceptive Advisors's portfolio in Q2 2026, its #63 holding.
  • Perceptive Advisors first reported a position in Palisade Bio in Q4 2025 and has held it in 3 quarters since.
  • Perceptive Advisors's Palisade Bio position peaked at $28.3M in Q4 2025.
  • 124 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.